A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration

被引：0
|
作者：
de Motta, Laura Lores [1 ]
Van Asten, Freekje [1 ]
Muether, Philipp S. [2 ]
Smailhodzic, Dzenita [1 ]
Chen, John C. [3 ]
Koenekoop, Robert K. [3 ,4 ,5 ]
Fauser, Sascha [2 ]
Hoyng, Carel C. B. [1 ]
Den Hollander, Anneke I. [1 ,6 ]
de Jong, Eiko [1 ]
机构：
[1] Radboud Univ Nijmegen, Med Ctr, Dept Ophthalmol, NL-6525 ED Nijmegen, Netherlands
[2] Univ Hosp Cologne, Dept Ophthalmol, Cologne, Germany
[3] McGill Univ, Dept Ophthalmol, Ctr Hlth, Montreal, PQ H3A 2T5, Canada
[4] McGill Univ, Dept Pediat Surg, Ctr Hlth, Montreal, PQ, Canada
[5] McGill Univ, Dept Human Genet, Ctr Hlth, Montreal, PQ, Canada
[6] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 ED Nijmegen, Netherlands
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2015年 / 56卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
3990
引用
收藏
页数：3
相关论文
共 50 条
  • [1] A genetic variant in NRP1 is associated with worse response to ranibizumab treatment in neovascular age-related macular degeneration
    Lores-Motta, Laura
    van Asten, Freekje
    Muether, Philipp S.
    Smailhodzic, Dzenita
    Groenewoud, Joannes M.
    Omar, Amer
    Chen, John
    Koenekoop, Robert K.
    Fauser, Sascha
    Hoyng, Carel B.
    den Hollander, Anneke I.
    de Jong, Eiko K.
    PHARMACOGENETICS AND GENOMICS, 2016, 26 (01): : 20 - 27
  • [2] Ranibizumab for neovascular age-related macular degeneration
    Rosenfeld, Philip J.
    Brown, David M.
    Heier, Jeffrey S.
    Boyer, David S.
    Kaiser, Peter K.
    Chung, Carol Y.
    Kim, Robert Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (14): : 1419 - 1431
  • [3] Ranibizumab for neovascular age-related macular degeneration
    Hernandez-Pastor, Luis Javier
    Ortega, Ana
    Garcia-Layana, Alfredo
    Giraldez, Joaquin
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (19) : 1805 - 1814
  • [4] Ranibizumab for neovascular age-related macular degeneration
    Gillies, Mark C.
    Wong, Tien Y.
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (07): : 748 - 749
  • [5] Ranibizumab in neovascular age-related macular degeneration
    Eng, Kenneth T.
    Kertes, Peter J.
    CLINICAL INTERVENTIONS IN AGING, 2006, 1 (04) : 451 - 466
  • [6] Treatment of neovascular age-related macular degeneration with Ranibizumab/LucentisTM
    Michels, S
    Rosenfeld, PJ
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 2005, 222 (06) : 480 - 484
  • [7] Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
    Kourlas, Helen
    Abrams, Paris
    CLINICAL THERAPEUTICS, 2007, 29 (09) : 1850 - 1861
  • [8] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [9] Ranibizumab: treatment in patients with neovascular age-related macular degeneration
    Pieramici, Dante J.
    Avery, Robert L.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2006, 6 (11) : 1237 - 1245
  • [10] GENETIC FACTORS ASSOCIATED WITH RESPONSE TO INTRAVITREAL RANIBIZUMAB IN KOREAN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Park, Un Chul
    Shin, Joo Young
    Kim, Sang Jin
    Shin, Eun Soon
    Lee, Jong Eun
    McCarthy, Linda C.
    Newcombe, Paul J.
    Xu, Chun-Fang
    Chung, Hum
    Yu, Hyeong Gon
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (02): : 288 - 297
12345